Early reperfusion strategy for acute myocardial infarction:a need for clinical implementation  

作　　者：Yan ZHANG Yong HUO 

机构地区：[1]Department of Cardiology, Peking University First Hospital,Beijing 100034, China

出　　处：《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》2011年第8期629-632,共4页浙江大学学报（英文版）B辑（生物医学与生物技术）

摘　　要：Reperfusion is the key strategy in acute ST-segment elevation myocardial infarction (STEMI) care,and it is time-dependent.Shortening the time from symptom to reperfusion and choosing the optimal reperfusion strategy for STEMI patients are great challenges in practice.We need to improve upon the problems of low reperfusion rate,non-standardized treatment,and economic burden in STEMI care.This article briefly reviews the current status of reperfusion strategy in STEMI care,and also introduces what we will do to bridge the gap between the guidelines and implementation in the clinical setting through the upcoming China STEMI early reperfusion program.Reperfusion is the key strategy in acute ST-segment elevation myocardial infarction （STEMI） care, and it is time-dependent. Shortening the time from symptom to reperfusion and choosing the optimal reperfusion strategy for STEMI patients are great challenges in practice. We need to improve upon the problems of low reperfusion rate, non-standardized treatment, and economic burden in STEMI care. This article briefly reviews the current status of reperfusion strategy in STEMI care, and also introduces what we will do to bridge the gap between the guidelines and implementation in the clinical setting through the upcoming China STEMI early reperfusion program.

关 键 词：Acute ST-segment elevation myocardialinfarction （STEMI） REPERFUSION Percutaneous coronaryintervention （PCI） FIBRINOLYSIS 

分 类 号：R542.2[医药卫生—心血管疾病]